Dopamine receptors: molecular biology, biochemistry and behavioural aspects.

[1]  K. Gustafsson,et al.  Remoxipride shows low propensity to block functional striatal dopamine D2 receptors in vitro. , 1994, European journal of pharmacology.

[2]  M. Johansson,et al.  Forskolin-induced up-regulation and functional supersensitivity of dopamine D2long receptors expressed by Ltk- cells. , 1994, European journal of pharmacology.

[3]  E. Friedman,et al.  Inhibition of Dopamine Agonist‐Induced Phosphoinositide Hydrolysis by Concomitant Stimulation of Cyclic AMP Formation in Brain Slices , 1994, Journal of neurochemistry.

[4]  Micaela Morelli,et al.  Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions , 1994, Trends in Neurosciences.

[5]  D. Jackson,et al.  Dopamine receptor antagonists block amphetamine and phencyclidine-induced motor stimulation in rats , 1994, Pharmacology Biochemistry and Behavior.

[6]  K. Jakobs,et al.  G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells. , 1994, The Journal of biological chemistry.

[7]  J. Slightom,et al.  D4 dopamine receptor-mediated signaling events determined in transfected Chinese hamster ovary cells. , 1994, The Journal of biological chemistry.

[8]  F. Artigas,et al.  Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors. , 1994, European journal of pharmacology.

[9]  M. Potenza,et al.  Functional expression and characterization of human D2 and D3 dopamine receptors , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  M. Paolillo,et al.  Opposing Actions of D1 and D2‐Dopamine Receptors on Arachidonic Acid Release and Cyclic AMP Production in Striatal Neurons , 1994, Journal of neurochemistry.

[11]  R. Todd,et al.  Characterization of the human dopamine D3 receptor expressed in transfected cell lines. , 1994, European journal of pharmacology.

[12]  R. Todd,et al.  Pharmacological and functional characterization of D2, D3 and D4 dopamine receptors in fibroblast and dopaminergic cell lines. , 1994, The Journal of pharmacology and experimental therapeutics.

[13]  M. Knowles,et al.  Expression and pharmacological characterization of the human D3 dopamine receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[14]  M. E. Lajiness,et al.  Activation of heterologously expressed D3 dopamine receptors: comparison with D2 dopamine receptors. , 1994, Molecular pharmacology.

[15]  P. Seeman,et al.  Dopamine D4 receptors elevated in schizophrenia , 1993, Nature.

[16]  Stephen J. Fink,et al.  Colocalization of D1 and D2 dopamine receptor mRNAs in striatal neurons , 1993, Brain Research.

[17]  H. Meltzer,et al.  Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. , 1993, The Journal of pharmacology and experimental therapeutics.

[18]  L. Chiodo,et al.  Transfected D2 short dopamine receptors inhibit voltage-dependent potassium current in neuroblastoma x glioma hybrid (NG108-15) cells. , 1993, Molecular pharmacology.

[19]  D. Surmeier,et al.  Are neostriatal dopamine receptors co-localized? , 1993, Trends in Neurosciences.

[20]  F. Gonon,et al.  Prefrontal cortex regulates burst firing and transmitter release in rat mesolimbic dopamine neurons studied in vivo , 1993, Neuroscience Letters.

[21]  N. Moore,et al.  NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists. , 1993, European journal of pharmacology.

[22]  D. Evans,et al.  Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications. , 1993, European journal of pharmacology.

[23]  P. Molinoff,et al.  Development of Polyclonal Anti‐D2 Dopamine Receptor Antibodies to Fusion Proteins: Inhibition of D2 Receptor–G Protein Interaction , 1993, Journal of neurochemistry.

[24]  D. Jackson,et al.  Unique binding characteristics of antipsychotic agents interacting with human dopamine D2A, D2B, and D3 receptors. , 1993, Molecular pharmacology.

[25]  J. Javitch,et al.  Differential visualization of dopamine D2 and D3 receptors in rat brain. , 1993, European journal of pharmacology.

[26]  E. Kawashima,et al.  Expression and characterization of human D4 dopamine receptors in baculovirus‐infected insect cells , 1993, FEBS letters.

[27]  J. Palacios,et al.  High resolution separation methods for the determination of intact human erythropoiesis stimulating agents. A review. , 2012, Analytica chimica acta.

[28]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[29]  S. Fuchs,et al.  A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. , 1993, The Journal of biological chemistry.

[30]  S. Nanko,et al.  Dopamine D4 receptor polymorphism and schizophrenia , 1993, The Lancet.

[31]  Sergi Ferré,et al.  Antagonistic A2a/D2 receptor interactions in the striatum as a basis for adenosine/dopamine interactions in the central nervous system , 1993 .

[32]  H. Vaudry,et al.  Effect of dopamine on adenylate cyclase activity, polyphosphoinositide metabolism and cytosolic calcium concentrations in frog pituitary melanotrophs. , 1993, The Journal of endocrinology.

[33]  S. Snyder,et al.  Cloning and expression of an adenylyl cyclase localized to the corpus striatum , 1993, Nature.

[34]  E. Borrelli,et al.  Preferential coupling between dopamine D2 receptors and G-proteins. , 1993, Molecular endocrinology.

[35]  P. Molinoff,et al.  Expression and characterization of the rat D3 dopamine receptor: pharmacologic properties and development of antibodies. , 1993, The Journal of pharmacology and experimental therapeutics.

[36]  Coupling of D2 and D3 dopamine receptors to G‐proteins , 1993, FEBS letters.

[37]  D. Collier,et al.  Dopamine D4 receptor subtypes and response to clozapine , 1993, The Lancet.

[38]  P. Strange,et al.  Differences in the Ligand Binding Properties of the Short and Long Versions of the D2 Dopamine Receptor , 1993, Journal of neurochemistry.

[39]  K. Neve,et al.  Dopamine D2 receptor stimulation of Na+/H+ exchange assessed by quantification of extracellular acidification. , 1992, The Journal of biological chemistry.

[40]  R. Todd,et al.  Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[41]  P. Watson,et al.  Molecular diversity in the adenylylcyclase family. Evidence for eight forms of the enzyme and cloning of type VI. , 1992, The Journal of biological chemistry.

[42]  K. Fuxe,et al.  Adenosine-dopamine interactions in the brain , 1992, Neuroscience.

[43]  P. Seeman.  Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[44]  D. Grandy,et al.  Differential Sensitivity of the Short and Long Human Dopamine D2 Receptor Subtypes to Protein Kinase C , 1992, Journal of neurochemistry.

[45]  D. Grandy,et al.  Distribution of D5 dopamine receptor mRNA in rat brain , 1992, Neuroscience Letters.

[46]  J. Morrison,et al.  Localization of multiple dopamine receptor subtype mRNAs in human and monkey motor cortex and striatum. , 1992, Brain research. Molecular brain research.

[47]  C. D. Livingstone,et al.  Molecular modelling of D2-like dopamine receptors. , 1992, The Biochemical journal.

[48]  J. W. Parce,et al.  The cytosensor microphysiometer: biological applications of silicon technology. , 1992, Science.

[49]  N. Pollock,et al.  Serine mutations in transmembrane V of the dopamine D1 receptor affect ligand interactions and receptor activation. , 1992, The Journal of biological chemistry.

[50]  M. Martres,et al.  Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[51]  P. Löschmann,et al.  NBQX (6-nitro-sulfamoyl-benzo-quinoxaline-dione) and CPP (3-carboxy- piperazin-propyl phosphonic acid) potentiate dopamine agonist induced rotations in substantia nigra lesioned rats , 1992, Neuroscience Letters.

[52]  P. H. Andersen,et al.  Dopamine receptor occupancy in vivo: behavioral correlates using NNC-112, NNC-687 and NNC-756, new selective dopamine D1 receptor antagonists. , 1992, European journal of pharmacology.

[53]  J. Leysen,et al.  Autoradiographic evidence for the occlusion of rat brain dopamine D3 receptors in vivo. , 1992, European journal of pharmacology.

[54]  G. Chouvet,et al.  Inhibition of nigral dopamine neurons by systemic and local apomorphine: Possible contribution of dendritic autoreceptors , 1992, Neuroscience.

[55]  K. Neve,et al.  Contributions of Conserved Serine Residues to the Interactions of Ligands with Dopamine D2 Receptors , 1992, Journal of Neurochemistry.

[56]  L. Weinstein,et al.  Receptor-effector coupling by G proteins: implications for normal and abnormal signal transduction. , 1992, Endocrine reviews.

[57]  P. Seeman,et al.  Multiple dopamine D4 receptor variants in the human population , 1992, Nature.

[58]  D. Piomelli,et al.  Participation of Prostaglandin E2 in Dopamine D2 Receptor‐Dependent Potentiation of Arachidonic Acid Release , 1992, Journal of neurochemistry.

[59]  F. Bymaster,et al.  Metabotropic Glutamate Receptor Activation Produces Extrapyramidal Motor System Activation That Is Mediated by Striatal Dopamine , 1992, Journal of neurochemistry.

[60]  E. French,et al.  Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons. , 1992, European journal of pharmacology.

[61]  D. Giuliani,et al.  Suppressive effect of the dopamine D2 receptor agonist B-HT 920 on rat grooming. , 1992, European journal of pharmacology.

[62]  Z. Kruk,et al.  Differences in evoked dopamine efflux in rat caudate putamen, nucleus accumbens and tuberculum olfactorium in the absence of uptake inhibition: influence of autoreceptors , 1992, British journal of pharmacology.

[63]  Y. Minabe,et al.  Effects produced by acute and chronic treatment with granisetron alone or in combination with haloperidol on midbrain dopamine neurons , 1992, European Neuropsychopharmacology.

[64]  C. Hodge,et al.  Alcohol Self‐Administration: Role of Mesolimbic Dopamine a , 1992, Annals of the New York Academy of Sciences.

[65]  P. Kalivas,et al.  Dopamine depletion produces augmented behavioral responses to a Mu‐, but not a delta‐opioid receptor agonist in the nucleus accumbens: Lack of a role for receptor upregulation , 1992, Synapse.

[66]  F. H. Lopes da Silva,et al.  Presynaptic dopamine D1 receptors attenuate excitatory and inhibitory limbic inputs to the shell region of the rat nucleus accumbens studied in vitro. , 1992, Journal of neurophysiology.

[67]  R. Weiner,et al.  Dissociation of dopamine from its receptor as a signal in the pleiotropic hypothalamic regulation of prolactin secretion. , 1992, Endocrine reviews.

[68]  P. Kalivas,et al.  Microinjection of the D2 agonist quinpirole into the A10 dopamine region blocks amphetamine-, but not cocaine-stimulated motor activity. , 1992, The Journal of pharmacology and experimental therapeutics.

[69]  K. Kidd,et al.  The D4 dopamine receptor (DRD4) maps to distal 11p close to HRAS. , 1992, Genomics.

[70]  J. C. Stoof,et al.  Dopamine D2 receptor stimulation differentially affects voltage‐activated calcium channels in rat pituitary melanotropic cells. , 1992, The Journal of physiology.

[71]  M. Martin-Iverson,et al.  Synergistic behavioural effects of dopamine D1 and D2 receptor agonists are determined by circadian rhythms. , 1992, European journal of pharmacology.

[72]  R. Layer,et al.  Stimulation of locomotor activity by intra-accumbens AMPA is not inhibited by neonatal 6-hydroxydopamine-induced lesions , 1992, Neuroscience Letters.

[73]  L. Cazin,et al.  Voltage-dependent modulation of calcium current by GTPγS and dopamine in cultured frog pituitary melanotrophs , 1992, Neuroscience Letters.

[74]  U. Ungerstedt,et al.  Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission , 1992, Brain Research.

[75]  M. Martres,et al.  Pharmacology of human dopamine D3 receptor expressed in a mammalian cell line: comparison with D2 receptor. , 1992, European journal of pharmacology.

[76]  M. Starr,et al.  Putative Neurotoxicity of SKF 38393 and Other D1 Dopaminergic Drugs Investigated in Rat Striatum , 1992, Journal of neurochemistry.

[77]  A. Deutch,et al.  Dopaminergic mechanisms in the pathogenesis of schizophrenia 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[78]  T. Kameyama,et al.  Effects of dopamine receptor agonists on passive avoidance learning in mice: interaction of dopamine D1 and D2 receptors. , 1992, European journal of pharmacology.

[79]  G. Golden,et al.  In vivo modulation of excitatory amino acid receptors: microdialysis studies on N-methyl-d-aspartate-evoked striatal dopamine release and effects of antagonists , 1992, Brain Research.

[80]  N. Ozaki,et al.  Differential effect of self-stimulation on dopamine release and metabolism in the rat medial frontal cortex, nucleus accumbens and striatum studied by in vivo microdialysis , 1992, Brain Research.

[81]  E. Abercrombie,et al.  Extracellular dopamine in striatum: Influence of nerve impulse activity in medial forebrain bundle and local glutamatergic input , 1992, Neuroscience.

[82]  M. E. Meyer,et al.  Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats , 1992, Pharmacology Biochemistry and Behavior.

[83]  R. Trifunovic,et al.  Nonserotonergic control of nucleus accumbens dopamine metabolism by the median raphe nucleus , 1992, Pharmacology Biochemistry and Behavior.

[84]  F. Karoum,et al.  Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol , 1992, British journal of pharmacology.

[85]  F. Dajas,et al.  Catalepsy induced by striatal acetylcholinesterase inhibition with fasciculin in rats , 1992, Pharmacology Biochemistry and Behavior.

[86]  F. J. White,et al.  Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation , 1992, Synapse.

[87]  R. Wise,et al.  Localization of drug reward mechanisms by intracranial injections , 1992, Synapse.

[88]  J. Bockaert,et al.  Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cells , 1992, Neuron.

[89]  M. Martres,et al.  The third dopamine receptor (D3) as a novel target for antipsychotics. , 1992, Biochemical pharmacology.

[90]  O. Hornykiewicz,et al.  Functional sensitization of striatal dopamine D1 receptors in the 6-hydroxydopamine-lesioned rat , 1992, Brain Research.

[91]  P. Seeman,et al.  Autoradiographic localization of [3H]quinpirole binding to dopamine D2 and D3 receptors in rat brain. , 1992, European journal of pharmacology.

[92]  Effects of estradiol on the ontogenesis of striatal dopamine D1 and D2 receptor sites in male and female rats , 1992, Brain Research.

[93]  H. Robertson.  Synergistic Interactions of D1- and D2-Selective Dopamine Agonists in Animal Models for Parkinson’s Disease: Sites of Action and Implications for the Pathogenesis of Dyskinesias , 1992, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[94]  L. Stein,et al.  Receptor subtypes in opioid and stimulant reward. , 1992, Pharmacology & toxicology.

[95]  R. Todd,et al.  The rat dopamine D4 receptor: sequence, gene structure, and demonstration of expression in the cardiovascular system. , 1992, The New biologist.

[96]  D. Clark,et al.  Iontophoretically administered drugs acting at the N‐methyl‐D‐aspartate receptor modulate burst firing in A9 dopamine neurons in the rat , 1992, Synapse.

[97]  C. J. Schmidt,et al.  5-HT2 receptor antagonists reverse amphetamine-induced slowing of dopaminergic neurons by interfering with stimulated dopamine synthesis. , 1992, The Journal of pharmacology and experimental therapeutics.

[98]  J. Kornhuber,et al.  Glutamatergic-dopaminergic balance in the brain. Its importance in motor disorders and schizophrenia. , 1992, Arzneimittel-Forschung.

[99]  C. Destrade,et al.  Locomotor bias produced by intra-accumbens injection of dopamine agonists and antagonists , 1992, Pharmacology Biochemistry and Behavior.

[100]  A. Deutch,et al.  Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell , 1992, Neuroscience.

[101]  C. Sánchez,et al.  Effects on body temperature in mice differentiate between dopamine D2 receptor agonists with high and low efficacies. , 1992, European journal of pharmacology.

[102]  T. Skarsfeldt.  Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: Acute and repeated treatment , 1992, Synapse.

[103]  M. Starr,et al.  Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801 , 1992, Journal of neural transmission. Parkinson's disease and dementia section.

[104]  D. Sibley,et al.  Molecular biology of dopamine receptors. , 1992, Trends in pharmacological sciences.

[105]  G. Di Chiara,et al.  Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression. , 1992, The Journal of pharmacology and experimental therapeutics.

[106]  A. Grace.  The depolarization block hypothesis of neuroleptic action: implications for the etiology and treatment of schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[107]  J. Tassin.  NE/DA interactions in prefrontal cortex and their possible roles as neuromodulators in schizophrenia. , 1992, Journal of neural transmission. Supplementum.

[108]  D. Jackson,et al.  Preferential stimulation of locomotor activity by ventral tegmental microinjections of (-)-nicotine. , 1992, Pharmacology & toxicology.

[109]  G. Reynolds.  Developments in the drug treatment of schizophrenia. , 1992, Trends in pharmacological sciences.

[110]  D. S. Zahm,et al.  Specificity in the projection patterns of accumbal core and shell in the rat , 1991, Neuroscience.

[111]  A. Grace.  Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia , 1991, Neuroscience.

[112]  J. Palacios,et al.  Adenosine A2 receptors: Selective localization in the human basal ganglia and alterations with disease , 1991, Neuroscience.

[113]  Positive and negative interactions in the behavioural expression of d1 and D2 receptor stimulation in a model of parkinsonism: Role of priming , 1991, Neuroscience.

[114]  M. Besson,et al.  Synergism between D1 and D2 dopamine receptors in the inhibition of the evoked release of [3H]GABA in the rat prefrontal cortex , 1991, Neuroscience.

[115]  L. Cazin,et al.  Dopamine-induced inhibition of action potentials in cultured frog pituitary melanotrophs is mediated through activation of potassium channels and inhibition of calcium and sodium channels , 1991, Neuroscience.

[116]  A. Gratton,et al.  Effects of local delta and mu opioid receptor activation on basal and stimulated dopamine release in striatum and nucleus accumbens of rat: An in vivo electrochemical study , 1991, Neuroscience.

[117]  L. Cazin,et al.  Dopamine regulates the electrical activity of frog melanotrophs through a G protein-mediated mechanism , 1991, Neuroscience.

[118]  S. Watson,et al.  Distribution of D2 dopamine receptor mRNA in the primate brain , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[119]  H. Akil,et al.  A comparison of D1 receptor binding and mRNA in rat brain using receptor autoradiographic and in situ hybridization techniques , 1991, Neuroscience.

[120]  D. Ward,et al.  Human dopamine D5 receptor pseudogenes. , 1991, Gene.

[121]  T. Hökfelt,et al.  Galanin inhibits the potassium-evoked release of acetylcholine and the muscarinic receptor-mediated stimulation of phosphoinositide turnover in slices of monkey hippocampus , 1991, Brain Research.

[122]  W. Woolverton,et al.  Antagonism of quinpirole by (+)-AJ 76: possible involvement of D3 receptors. , 1991, European journal of pharmacology.

[123]  Characterization of dopamine autoreceptors in the amygdala: A fast cyclic voltammetric study in vitro , 1991, Neuroscience Letters.

[124]  D. Schoepp,et al.  Intrastriatal injection of a selective metabotropic excitatory amino acid receptor agonist induces contralateral turning in the rat. , 1991, The Journal of pharmacology and experimental therapeutics.

[125]  G S Oxford,et al.  D2 dopamine receptor activation of potassium channels in identified rat lactotrophs: whole-cell and single-channel recording , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[126]  T. Branchek,et al.  Molecular cloning and characterization of a high affinity dopamine receptor (D1 beta) and its pseudogene. , 1991, The Journal of biological chemistry.

[127]  K. Rasmussen,et al.  The 5-HT3 receptor antagonist zatosetron decreases the number of spontaneously active A10 dopamine neurons. , 1991, European journal of pharmacology.

[128]  A. Gilman,et al.  Cloning and expression of a widely distributed (type IV) adenylyl cyclase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Bruno Giros,et al.  Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA , 1991, Brain Research.

[130]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[131]  L. Snyder,et al.  Alternative transcripts of the rat and human dopamine D3 receptor. , 1991, Biochemical and biophysical research communications.

[132]  D. Grandy,et al.  Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[133]  A. Grace,et al.  Midbrain dopamine system electrophysiological functioning: A review and new hypothesis , 1991, Synapse.

[134]  J. Ferkany,et al.  Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine , 1991, Neuropharmacology.

[135]  D. Clark,et al.  Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue. , 1991, European journal of pharmacology.

[136]  O. Hornykiewicz,et al.  Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum. , 1991, European journal of pharmacology.

[137]  P. Seeburg,et al.  Antipeptide antibodies differentiate between long and short isoforms of the D2 dopamine receptor. , 1991, Biochemical and biophysical research communications.

[138]  I. Sylte,et al.  Molecular dynamics of dopamine at the D2 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[139]  L. Wallace,et al.  The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA , 1991, Brain Research.

[140]  M. Martres,et al.  Dopamine activation of the arachidonic acid cascade as a basis for D1D2 receptor synergism , 1991, Nature.

[141]  G. Schultz,et al.  Assignment of G-protein subtypes to specific receptors inducing inhibition of calcium currents , 1991, Nature.

[142]  M. Caron,et al.  Cloning, molecular characterization, and chromosomal assignment of a gene encoding a second D1 dopamine receptor subtype: differential expression pattern in rat brain compared with the D1A receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[143]  M. Wolf,et al.  Characterization of the distribution of Gαo in rat striatal synaptosomes and its colocalization with tyrosine hydroxylase , 1991, Synapse.

[144]  D. Grandy,et al.  Molecular biology of the dopamine receptors. , 1991, European journal of pharmacology.

[145]  S. Sealfon,et al.  Either isoform of the dopamine D2 receptor can mediate dopaminergic repression of the rat prolactin promoter , 1991, Molecular and Cellular Endocrinology.

[146]  J. Vincent,et al.  Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. , 1991, Endocrinology.

[147]  T. Napier,et al.  Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons. , 1991, European journal of pharmacology.

[148]  M. Galloway,et al.  Facilitation of dopamine release in vivo by serotonin agonists: studies with microdialysis. , 1991, European journal of pharmacology.

[149]  R. Mailman,et al.  Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-induced parkinsonism in monkeys. , 1991, European journal of pharmacology.

[150]  K. Kidd,et al.  No linkage between D2 dopamine receptor gene region and schizophrenia. , 1991, Archives of general psychiatry.

[151]  A. Surprenant,et al.  Dopamine actions on calcium currents, potassium currents and hormone release in rat melanotrophs. , 1991, The Journal of physiology.

[152]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[153]  M. Geyer,et al.  Spatial and temporal patterning distinguishes the locomotor activating effects of dizocilpine and phencyclidine in rats , 1991, Neuropharmacology.

[154]  N. O'Regan,et al.  The effects of dopaminergic agonists and antagonists on the frequency-response function for hypothalamic self-stimulation in the rat , 1991, Pharmacology Biochemistry and Behavior.

[155]  M. Martres,et al.  Shorter variants of the D3 dopamine receptor produced through various patterns of alternative splicing. , 1991, Biochemical and biophysical research communications.

[156]  Melvin I. Simon,et al.  Diversity of G proteins in signal transduction , 1991, Science.

[157]  J. Wickens,et al.  Two dynamic modes of striatal function under dopaminergic‐cholinergic control: Simulation and analysis of a model , 1991, Synapse.

[158]  M. Fillenz,et al.  Presynaptic Adenosine A2 and N‐Methyl‐D‐Aspartate Receptors Regulate Dopamine Synthesis in Rat Striatal Synaptosomes , 1991, Journal of neurochemistry.

[159]  M. Froimowitz,et al.  Conformational properties of semirigid antipsychotic drugs: the pharmacophore for dopamine D-2 antagonist activity. , 1991, Journal of medicinal chemistry.

[160]  M. Caron,et al.  Localization of D1 dopamine receptor mRNA in brain supports a role in cognitive, affective, and neuroendocrine aspects of dopaminergic neurotransmission. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[161]  J. Palacios,et al.  Visualization of a dopamine D1 receptor mRNA in human and rat brain. , 1991, Brain research. Molecular brain research.

[162]  K. Chergui,et al.  Burst firing of mesencephalic dopamine neurons is inhibited by somatodendritic application of kynurenate. , 1991, Acta physiologica Scandinavica.

[163]  Susan R. George,et al.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.

[164]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[165]  D. Jackson,et al.  Role of dopamine and GABA in the control of motor activity elicited from the rat nucleus accumbens , 1991, Pharmacology Biochemistry and Behavior.

[166]  K. Neve,et al.  Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[167]  G. Golden,et al.  Partial characterization of kainic acid-induced striatal dopamine release using in vivo microdialysis , 1991, Brain Research.

[168]  T. Ott,et al.  CCK-8 modulates D2 receptor agonist-induced hypermotility in the nucleus accumbens , 1991, Brain Research Bulletin.

[169]  A. Levey,et al.  D1 and D2 dopamine receptor mRNA in rat brain. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[170]  D. Sibley,et al.  Transfected D2 dopamine receptors mediate the potentiation of arachidonic acid release in Chinese hamster ovary cells. , 1991, Molecular pharmacology.

[171]  R. Todd,et al.  Analysis of the Structure and Expression of the Human Dopamine D2A Receptor Gene , 1991, Journal of neurochemistry.

[172]  V. Hillegaart,et al.  Region-selective inhibition of male rat sexual behavior and motor performance by localized forebrain 5-HT injections: a comparison with effects produced by 8-OH-DPAT , 1991, Behavioural Brain Research.

[173]  A. Cools,et al.  Role of the nucleus accumbens in social memory in rats , 1991, Brain Research Bulletin.

[174]  L. Snyder,et al.  Distribution of dopamine D2 receptor mRNA splice variants in the rat by solution mhybridization/protection assay , 1991, Neuroscience Letters.

[175]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: II. Postsynaptic dopamine agonism and adenosine antagonism of methylxanthines in short-term reserpinized mice. , 1991, European journal of pharmacology.

[176]  U. Ungerstedt,et al.  Postsynaptic dopamine/adenosine interaction: I. Adenosine analogues inhibit dopamine D2-mediated behaviour in short-term reserpinized mice. , 1991, European journal of pharmacology.

[177]  J. Wamsley,et al.  Quinolinic acid lesion of nucleus accumbens reduces D1 but not D2 dopamine receptors: an autoradiographic study. , 1991, Life sciences.

[178]  T. Heffner,et al.  Dopamine autoreceptor agonists as potential antipsychotics. 2. (Aminoalkoxy)-4H-1-benzopyran-4-ones. , 1991, Journal of medicinal chemistry.

[179]  A. Levitzki,et al.  The regulation of adenylyl cyclase by receptor-operated G proteins. , 1991, Pharmacology & therapeutics.

[180]  M. Le Moal,et al.  Mesocorticolimbic dopaminergic network: functional and regulatory roles. , 1991, Physiological reviews.

[181]  G. Mogenson,et al.  The contribution of basal forebrain to limbic-motor integration and the mediation of motivation to action. , 1991, Advances in experimental medicine and biology.

[182]  M. Zarrindast,et al.  Blockade of both D-1 and D-2 dopamine receptors may induce catalepsy in mice. , 1991, General pharmacology.

[183]  J. C. Stoof,et al.  Muscarinic receptor activation attenuates D2 dopamine receptor mediated inhibition of acetylcholine release in rat striatum: Indications for a common signal transduction pathway , 1990, Neuroscience.

[184]  A. Kelley,et al.  The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum , 1990, Neuroscience.

[185]  C. Gerfen,et al.  D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons. , 1990, Science.

[186]  Randall R. Reed,et al.  Identification of a specialized adenylyl cyclase that may mediate odorant detection. , 1990, Science.

[187]  J. Gray,et al.  Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: Comparison with caudate-putamen , 1990, Neuropharmacology.

[188]  C. Taylor,et al.  The role of G proteins in transmembrane signalling. , 1990, The Biochemical journal.

[189]  D. Grandy,et al.  A human D1 dopamine receptor gene is located on chromosome 5 at q35.1 and identifies an EcoRI RFLP. , 1990, American journal of human genetics.

[190]  A. Imperato,et al.  Dopamine release in the nucleus caudatus and in the nucleus accumbens is under glutamatergic control through non-NMDA receptors: a study in freely-moving rats , 1990, Brain Research.

[191]  H. Vaudry,et al.  Thyrotrophin-releasing hormone stimulates polyphosphoinositide metabolism in the frog neurointermediate lobe. , 1990, Journal of molecular endocrinology.

[192]  G. Wooten,et al.  Selective localization of striatal D1 receptors to striatonigral neurons , 1990, Brain Research.

[193]  T. Klockgether,et al.  NMDA antagonists potentiate antiparkinsonian actions of L‐dopa in monoamine‐depleted rats , 1990, Annals of neurology.

[194]  P. Greengard,et al.  Inhibition by dopamine of (Na+ + K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism , 1990, Nature.

[195]  J. Vincent,et al.  A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium currents by dopamine in rat lactotrophs , 1990, Brain Research.

[196]  Bruno Giros,et al.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics , 1990, Nature.

[197]  R. Rozmahel,et al.  Human dopamine D1 receptor encoded by an intronless gene on chromosome 5 , 1990, Nature.

[198]  D. Grandy,et al.  Cloning and expression of human and rat Dt dopamine receptors , 1990, Nature.

[199]  M. Caron,et al.  Molecular cloning and expression of the gene for a human D1 dopamine receptor , 1990, Nature.

[200]  J. Vincent,et al.  Dopamine inhibits two characterized voltage-dependent calcium currents in identified rat lactotroph cells. , 1990, Endocrinology.

[201]  C. Gerfen,et al.  Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[202]  D. Jackson,et al.  α1 (but not α2)-Adrenoceptor Agonists in Combination with the Dopamine D2 Agonist Quinpirole Produce Locomotor Stimulation in Dopamine-Depleted Mice , 1990 .

[203]  H. Akil,et al.  Localization of dopamine D2 receptor mRNA and D1 and D2 receptor binding in the rat brain and pituitary: an in situ hybridization- receptor autoradiographic analysis , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[204]  G. Di Chiara,et al.  MK-801 potentiates dopaminergic D1 but reduces D2 responses in the 6-hydroxydopamine model of Parkinson's disease. , 1990, European journal of pharmacology.

[205]  L. G. Moss,et al.  Molecular cloning of a novel splice variant of the alpha subunit of the mammalian Go protein. , 1990, The Journal of biological chemistry.

[206]  M. Piercey,et al.  Electrophysiological effects of dopamine autoreceptor antagonists, (+)-AJ 76 and (+)-UH 232. , 1990, European journal of pharmacology.

[207]  P. Goldman-Rakic,et al.  New frontiers in basal ganglia research , 1990, Trends in Neurosciences.

[208]  V. Hillegaart,et al.  Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat , 1990, Physiology & Behavior.

[209]  J. Vincent,et al.  Effects of dopamine on voltage-dependent potassium currents in identified rat lactotroph cells. , 1990, Neuroendocrinology.

[210]  J. Meldolesi,et al.  Differential coupling of dopaminergic D2 receptors expressed in different cell types. Stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis in LtK- fibroblasts, hyperpolarization, and cytosolic-free Ca2+ concentration decrease in GH4C1 cells. , 1990, The Journal of biological chemistry.

[211]  P. Portoghese,et al.  Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. , 1990, European journal of pharmacology.

[212]  E. Friedman,et al.  Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain. , 1990, The Journal of pharmacology and experimental therapeutics.

[213]  M. Carlsson,et al.  Interfering with glutamatergic neurotransmission by means of NMDA antagonist administration discloses the locomotor stimulatory potential of other transmitter systems , 1990, Pharmacology Biochemistry and Behavior.

[214]  J. Kebabian,et al.  Two forms of the rat D2 dopamine receptor as revealed by the polymerase chain reaction , 1990, FEBS letters.

[215]  R. Kasser,et al.  The effect of intraventricular administration of the 5-HT3 receptor agonist 2-methylserotonin on the release of dopamine in the nucleus accumbens: an in vivo chronocoulometric study , 1990, Brain Research.

[216]  R. Iyengar,et al.  Specificity of receptor-G protein interactions. Discrimination of Gi subtypes by the D2 dopamine receptor in a reconstituted system. , 1990, The Journal of biological chemistry.

[217]  T. Di Paolo,et al.  Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists. , 1990, European journal of pharmacology.

[218]  P. Kalivas,et al.  Changes in γ-aminobutyric acid, μ-opioid and neurotensin receptors in the accumbens-pallidal projection after discrete quinolinic acid lesions in the nucleus accumbens , 1990, Brain Research.

[219]  S. Ojeda,et al.  Epoxygenase products of arachidonic acid are endogenous constituents of the hypothalamus involved in D2 receptor-mediated, dopamine-induced release of somatostatin. , 1990, Endocrinology.

[220]  Q. Pittman,et al.  Electrophysiological properties of neuroendocrine cells of the intact rat pars intermedia: multiple calcium currents , 1990, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[221]  R. Todd,et al.  Organization and expression of the rat D2A receptor gene: identification of alternative transcripts and a variant donor splice site. , 1990, Biochemistry.

[222]  K. Neve,et al.  Coupling of a cloned rat dopamine-D2 receptor to inhibition of adenylyl cyclase and prolactin secretion. , 1990, The Journal of biological chemistry.

[223]  C. Reavill,et al.  Locomotor activity in rats after administration of nicotinic agonists intracerebrally , 1990, British journal of pharmacology.

[224]  C. Allen,et al.  D2 dopamine receptors modulate calcium channel currents and catecholamine secretion in bovine adrenal chromaffin cells. , 1990, The Journal of pharmacology and experimental therapeutics.

[225]  P. Greengard,et al.  Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices , 1990, Nature.

[226]  G. F. Hess,et al.  A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus , 1990, Nature.

[227]  C. Ashby,et al.  Chronic BRL 43694, a selective 5-HT3 receptor antagonist, fails to alter the number of spontaneously active midbrain dopamine neurons. , 1990, European journal of pharmacology.

[228]  M. Martres,et al.  [Gene cloning of human dopaminergic D3 receptor and identification of its chromosome]. , 1990, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[229]  J. Clemens,et al.  Effect of direct and indirect dopamine agonists on brain extracellular ascorbate levels in the striatum and nucleus accumbens of awake rats. , 1990, Life sciences.

[230]  D. Weiner,et al.  Molecular cloning and expression of a dopamine D2 receptor from human retina. , 1990, Molecular pharmacology.

[231]  A. Albanese.  EXTRAPYRAMIDAL SYSTEM, MOTOR GANGLIA AND MOVEMENT DISORDERS , 1990, Reviews in the neurosciences.

[232]  D. Coward,et al.  Partial dopamine-agonistic and atypical neuroleptic properties of the amino-ergolines SDZ 208-911 and SDZ 208-912. , 1990, The Journal of pharmacology and experimental therapeutics.

[233]  F. J. White,et al.  Inhibition of dopamine synthesis in striatal slices by the D1 agonist SKF 38393 is not mediated by D1 dopamine receptors , 1990, Synapse.

[234]  M. Carlsson,et al.  The non-competitive NMDA antagonists MK-801 and PCP, as well as the competitive NMDA antagonist SDZ EAA494 (D-CPPene), interact synergistically with clonidine to promote locomotion in monoamine-depleted mice. , 1990, Life sciences.

[235]  D. Grandy,et al.  Genetic linkage is excluded for the D2-dopamine receptor lambda HD2G1 and flanking loci on chromosome 11q22-q23 in Tourette syndrome. , 1990, Human heredity.

[236]  R. Robertson,et al.  Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism. , 1990, Life sciences.

[237]  T. Svensson,et al.  Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo. , 1990, Pharmacology & toxicology.

[238]  L. Birnbaumer,et al.  G proteins in signal transduction. , 1990, Annual review of pharmacology and toxicology.

[239]  A. Mcgeorge,et al.  The organization of the projection from the cerebral cortex to the striatum in the rat , 1989, Neuroscience.

[240]  Stephen P. H. Alexander,et al.  The cellular localization of adenosine receptors in rat neostriatum , 1989, Neuroscience.

[241]  C. Gerfen,et al.  Multiple D2 dopamine receptors produced by alternative RNA splicing , 1989, Nature.

[242]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[243]  G. Robertson,et al.  D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour , 1989, Brain Research.

[244]  J. Green,et al.  Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum. , 1989, The Journal of pharmacology and experimental therapeutics.

[245]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[246]  C. Sánchez.  The effects of dopamine D-1 and D-2 receptor agonists on body temperature in male mice. , 1989, European journal of pharmacology.

[247]  L. Selbie,et al.  The major dopamine D2 receptor: molecular analysis of the human D2A subtype. , 1989, DNA.

[248]  D. Grandy,et al.  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. , 1989, American journal of human genetics.

[249]  C. Gerfen.  The neostriatal mosaic: striatal patch-matrix organization is related to cortical lamination. , 1989, Science.

[250]  A. Grace,et al.  Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[251]  H. Fibiger,et al.  Lack of tolerance to nicotine-induced dopamine release in the nucleus accumbens. , 1989, European journal of pharmacology.

[252]  R. Hitzemann,et al.  Long-term treatment with antipsychotics does not alter the phosphoinositide response to muscarinic or D2 dopaminergic agonists in rat striatum , 1989, Brain Research.

[253]  P. Calabresi,et al.  Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording , 1989, British journal of pharmacology.

[254]  R. Felder,et al.  The dopamine receptor in adult and maturing kidney. , 1989, The American journal of physiology.

[255]  K. Neve,et al.  Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line. , 1989, Molecular pharmacology.

[256]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[257]  C. Strader,et al.  Mapping the Functional Domains of the β-adrenergic Receptor , 1989 .

[258]  S. Fuchs,et al.  Association of two pertussis toxin‐sensitive G‐proteins with the D2‐dopamine receptor from bovine striatum. , 1989, The EMBO journal.

[259]  M. Caron,et al.  Phosphorylation sites on two domains of the beta 2-adrenergic receptor are involved in distinct pathways of receptor desensitization. , 1989, The Journal of biological chemistry.

[260]  T. Svensson,et al.  The 5-HT2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurons in vivo. , 1989, Acta physiologica Scandinavica.

[261]  V. Hillegaart,et al.  Effects of local application of 5-HT into the median and dorsal raphe nuclei on male rat sexual and motor behavior , 1989, Behavioural Brain Research.

[262]  C. Slaughter,et al.  Adenylyl cyclase amino acid sequence: possible channel- or transporter-like structure. , 1989, Science.

[263]  A. Imperato,et al.  5-HT3 receptors control dopamine release in the nucleus accumbens of freely moving rats , 1989, Neuroscience Letters.

[264]  G. Mogenson,et al.  Ventral pallidal neuronal responses to dopamine receptor stimulation in the nucleus accumbens , 1989, Brain Research.

[265]  J. C. Stoof,et al.  Stimulation of D‐2 Dopamine Receptors Decreases the Evoked In Vitro Release of [3H] Acetylcholine from Rat Neostriatum: Role of K+ and Ca2+ , 1989, Journal of neurochemistry.

[266]  G. Gessa,et al.  Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system. , 1989, European journal of pharmacology.

[267]  C. Felder,et al.  Dopamine-1-mediated stimulation of phospholipase C activity in rat renal cortical membranes. , 1989, The Journal of biological chemistry.

[268]  D. Jackson,et al.  Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats , 1989, Brain Research.

[269]  F. F. Weight,et al.  Quinine potently blocks single K+ channels activated by dopamine D-2 receptors in rat corpus striatum neurons. , 1989, European journal of pharmacology.

[270]  M. Caron,et al.  Palmitoylation of the human beta 2-adrenergic receptor. Mutation of Cys341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. , 1989, The Journal of biological chemistry.

[271]  L. Loopuijt.  Distribution of dopamine D-2 receptors in the rat striatal complex and its comparison with acetylcholinesterase , 1989, Brain Research Bulletin.

[272]  T. Svensson,et al.  Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo. , 1989, Acta physiologica Scandinavica.

[273]  R. Wise.  Neuroleptic-induced anhedonia: Recent studies , 1989, Schizophrenia Research.

[274]  P. Hicks.  The effect of serotonergic agents on haloperidol-induced catalepsy , 1989, Schizophrenia Research.

[275]  M. Palfreyman,et al.  Effect of acute and chronic MDL 73,147EF, a 5-HT3 receptor antagonist, on A9 and A10 dopamine neurons. , 1989, European journal of pharmacology.

[276]  H. Mount,et al.  Glutamate Stimulation of [3H]Dopamine Release from Dissociated Cell Cultures of Rat Ventral Mesencephalon , 1989, Journal of neurochemistry.

[277]  S. Hjorth,et al.  Synthesis and Release of Dopamine in Rat Brain: Comparison Between Substantia Nigra Pars Compacta, Pars Reticulata, and Striatum , 1989, Journal of neurochemistry.

[278]  M. Memo,et al.  Potassium channels involved in the transduction mechanism of dopamine D2 receptors in rat lactotrophs. , 1989, The Journal of physiology.

[279]  B. Westerink,et al.  Use of Calcium Antagonism for the Characterization of Drug‐Evoked Dopamine Release from the Brain of Conscious Rats Determined by Microdialysis , 1989, Journal of neurochemistry.

[280]  D. Clapham,et al.  G-protein βγ-subunits activate the cardiac muscarinic K+-channel via phospholipase A2 , 1989, Nature.

[281]  Takao Shimizu,et al.  Arachidonic acid metabolites as intracellular modulators of the G protein-gated cardiac K+ channel , 1989, Nature.

[282]  M. Durcan,et al.  NECA-induced hypomotility in mice: Evidence for a predominantly central site of action , 1989, Pharmacology Biochemistry and Behavior.

[283]  K. Jhamandas,et al.  Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen. , 1989, The Journal of pharmacology and experimental therapeutics.

[284]  J. Meldolesi,et al.  Mechanisms of signal transduction at the dopamine D2 receptor. , 1989, Trends in pharmacological sciences.

[285]  P. H. Andersen,et al.  Amphetamine discrimination: effects of dopamine receptor agonists. , 1989, European journal of pharmacology.

[286]  S. Hjorth,et al.  Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity. , 1989, European journal of pharmacology.

[287]  J. Ramos,et al.  Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors , 1989, Brain Research.

[288]  B. Costall,et al.  5-HT3 Receptors in the Central Nervous System , 1989 .

[289]  M. Caron,et al.  Structure of the adrenergic and related receptors. , 1989, Annual review of neuroscience.

[290]  F. Bordi,et al.  Behavioral recovery after irreversible inactivation of D-1 and D-2 dopamine receptors. , 1989, Life sciences.

[291]  A. Cools,et al.  The involvement of the nucleus accumbens in the ability of rats to switch to cue-directed behaviours. , 1989, Life sciences.

[292]  D. Jackson,et al.  The involvement of dopamine D1 and D2 receptors in the locomotor stimulation produced by (+)-amphetamine in naive and dopamine-depleted mice. , 1989, Pharmacology & toxicology.

[293]  Positive interaction between alpha-1 adrenergic and dopamine-2 receptors in locomotor activity of normo and supersensitive mice. , 1989, Life sciences.

[294]  R. Wise,et al.  Brain dopamine and reward. , 1989, Annual review of psychology.

[295]  J. Waddington,et al.  Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist. , 1989, Pharmacology & therapeutics.

[296]  J. Axelrod,et al.  The dopamine-1 agonist, SKF 82526, stimulates phospholipase-C activity independent of adenylate cyclase. , 1989, The Journal of pharmacology and experimental therapeutics.

[297]  J. Axelrod,et al.  Receptor-mediated activation of phospholipase A2 via GTP-binding proteins: arachidonic acid and its metabolites as second messengers , 1988, Trends in Neurosciences.

[298]  R. Tsien,et al.  Multiple types of neuronal calcium channels and their selective modulation , 1988, Trends in Neurosciences.

[299]  R. Iyengar,et al.  The G protein-gated atrial K+ channel is stimulated by three distinct GIα-subunits , 1988, Nature.

[300]  J. Nakai,et al.  Location of a region of the muscarinic acetylcholine receptor involved in selective effector coupling , 1988, FEBS letters.

[301]  R. Murphy,et al.  Cytochrome P-450 metabolism of arachidonic acid: formation and biological actions of "epoxygenase"-derived eicosanoids. , 1988, Pharmacological reviews.

[302]  C. Sinton,et al.  Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. , 1988, European journal of pharmacology.

[303]  T. Di Paolo,et al.  Repeated stimulation of D-1 dopamine receptors increases the circling response to bromocriptine in rats with a 6-OHDA lesion. , 1988, European journal of pharmacology.

[304]  C. Marsden,et al.  The D-1 dopamine receptor partial agonist, CY 208-243, exhibits antiparkinsonian activity in the MPTP-treated marmoset. , 1988, European journal of pharmacology.

[305]  X.-T. Hu,et al.  Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[306]  M. Goldstein,et al.  Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine. , 1988, European journal of pharmacology.

[307]  T. Robinson,et al.  Persistent sensitization of dopamine neurotransmission in ventral striatum (nucleus accumbens) produced by prior experience with (+)-amphetamine: a microdialysis study in freely moving rats , 1988, Brain Research.

[308]  P. Groves,et al.  Burst firing induced in midbrain dopamine neurons by stimulation of the medial prefrontal and anterior cingulate cortices , 1988, Brain Research.

[309]  A. Enz,et al.  Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity. , 1988, European journal of pharmacology.

[310]  J. Hyttel,et al.  Inactivation of dopamine D-1 or D-2 receptors differentially inhibits stereotypies induced by dopamine agonists in rats. , 1988, European journal of pharmacology.

[311]  S. Nahorski,et al.  Dopamine Receptor Stimulation Does Not Affect Phosphoinositide Hydrolysis in Slices of Rat Striatum , 1988, Journal of neurochemistry.

[312]  T. Svensson,et al.  Firing patterns of midbrain dopamine neurons: differences between A9 and A10 cells. , 1988, Acta physiologica Scandinavica.

[313]  S. Chaki,et al.  5-HT2 antagonists and minaprine block the 5-HT-induced inhibition of dopamine release from rat brain striatal slices. , 1988, European journal of pharmacology.

[314]  J. H. Carlson,et al.  Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation. , 1988, European journal of pharmacology.

[315]  H. Fibiger,et al.  Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[316]  C. Carter,et al.  Differential Control by N‐Methyl‐D‐Aspartate and Kainate of Striatal Dopamine Release In Vivo: A Trans‐Striatal Dialysis Study , 1988, Journal of neurochemistry.

[317]  A. Ashkenazi,et al.  Differential regulation of PI hydrolysis and adenylyl cyclase by muscarinic receptor subtypes , 1988, Nature.

[318]  M. Memo,et al.  Dopamine D2 receptor stimulation inhibits inositol phosphate generating system in rat striatal slices , 1988, Brain Research.

[319]  J. Meldolesi,et al.  Inhibition of inositol phosphate production is a late, Ca2+-dependent effect of D2 dopaminergic receptor activation in rat lactotroph cells. , 1988, The Journal of biological chemistry.

[320]  C. Strader,et al.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.

[321]  A. Crocker,et al.  Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity , 1988, Neuroscience Letters.

[322]  N. Mercuri,et al.  On the potassium conductance increase activated by GABAB and dopamine D2 receptors in rat substantia nigra neurones. , 1988, The Journal of physiology.

[323]  T. Chase,et al.  The D1 dopamine receptor in the rat brain: Quantitative autoradiographic localization using an iodinated ligand , 1988, Neuroscience.

[324]  K. Asin,et al.  Is dopamine involved in the hyperactivity produced by injections of muscimol into the median raphe nucleus? , 1988, Pharmacology Biochemistry and Behavior.

[325]  G. Isenberg,et al.  The alpha subunit of the GTP binding protein activates muscarinic potassium channels of the atrium. , 1988, Science.

[326]  M. Caron,et al.  Chimeric alpha 2-,beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. , 1988, Science.

[327]  The importance of dopaminergic neurotransmission in the hypermotility response produced by the administration of N-methyl-d -aspartic acid into the nucleus accumbens , 1988, Neuropharmacology.

[328]  B. Rudy,et al.  Diversity and ubiquity of K channels , 1988, Neuroscience.

[329]  M. Caron,et al.  Removal of phosphorylation sites from the β2-adrenergic receptor delays onset of agonist-promoted desensitization , 1988, Nature.

[330]  L. Cervo,et al.  8-hydroxy-2-(di-N-propylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidol-induced catalepsy by an action on raphe nuclei medianus and dorsalis , 1988, Neuropharmacology.

[331]  T. Kameyama,et al.  Opposite effects induced by low and high doses of apomorphine on single-trial passive avoidance learning in mice , 1988, Pharmacology Biochemistry and Behavior.

[332]  F. F. Weight,et al.  Single K+ channels activated by D2 dopamine receptors in acutely dissociated neurons from rat corpus striatum. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[333]  K. Fuxe,et al.  D1- and D2-receptor antagonist induce catalepsy via different efferent. Striatal pathways , 1988, Neuroscience Letters.

[334]  R. Harris-Warrick,et al.  An α 40 subunit of a GTP-Binding protein immunologically related to G0 mediates a dopamine-induced decrease of Ca2+ current in snail neurons , 1988, Neuron.

[335]  R. Hruska,et al.  Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum , 1988, Brain Research.

[336]  T. Haga,et al.  The interaction between D-2 dopamine receptors and GTP-binding proteins. , 1988, Molecular pharmacology.

[337]  K. Bogeso,et al.  Relative dopamine D1 and D2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. , 1988, Pharmacology & toxicology.

[338]  F. Gonon.  Nonlinear relationship between impulse flow and dopamine released by rat midbrain dopaminergic neurons as studied by in vivo electrochemistry , 1988, Neuroscience.

[339]  P. Seeman,et al.  Glycoprotein nature of D2 dopamine receptors , 1988, FEBS letters.

[340]  T. Skarsfeldt.  Effect of chronic treatment with SCH 23390 and haloperidol on spontaneous activity of dopamine neurones in substantia nigra pars compacta (SNC) and ventral tegmental area (VTA) in rats. , 1988, European journal of pharmacology.

[341]  T. Skarsfeldt.  Differential effects after repeated treatment with haloperidol, clozapine, thioridazine and tefludazine on SNC and VTA dopamine neurones in rats. , 1988, Life sciences.

[342]  J. Arnt.  The discriminative stimulus properties of the D-1 agonist SK&F 38393 and the D-2 agonist (-)-NPA are mediated by separate mechanisms. , 1988, Life sciences.

[343]  M. Caron,et al.  Molecular biology of adrenergic receptors. , 1988, Cold Spring Harbor symposia on quantitative biology.

[344]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[345]  R. Camsonne.  Dopamine receptors in brain and periphery: Some prospects , 1987, Neurochemistry International.

[346]  P. Seeman,et al.  Dopamine receptors in brain and periphery , 1987, Neurochemistry International.

[347]  C. Strader,et al.  Mutations that uncouple the beta-adrenergic receptor from Gs and increase agonist affinity. , 1987, The Journal of biological chemistry.

[348]  P. Greengard,et al.  Regulation of receptor function by protein phosphorylation , 1987 .

[349]  A. Beaudet,et al.  Serotonin axon terminals in the ventral tegmental area of the rat: fine structure and synaptic input to dopaminergic neurons , 1987, Brain Research.

[350]  A. Ashkenazi,et al.  Distinct primary structures, ligand‐binding properties and tissue‐specific expression of four human muscarinic acetylcholine receptors. , 1987, The EMBO journal.

[351]  B. Costall,et al.  Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain , 1987, British journal of pharmacology.

[352]  Gavin Kilpatrick,et al.  Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding , 1987, Nature.

[353]  A. Brown,et al.  A G protein directly regulates mammalian cardiac calcium channels. , 1987, Science.

[354]  J. Bockaert,et al.  An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. , 1987, The Journal of biological chemistry.

[355]  N. Mercuri,et al.  Dopamine acts on D2 receptors to increase potassium conductance in neurones of the rat substantia nigra zona compacta. , 1987, The Journal of physiology.

[356]  C. Strader,et al.  Structural features required for ligand binding to the beta‐adrenergic receptor. , 1987, The EMBO journal.

[357]  M. Caron,et al.  Cloning, sequencing, and expression of the gene coding for the human platelet alpha 2-adrenergic receptor. , 1987, Science.

[358]  J L Benovic,et al.  The multiple membrane spanning topography of the beta 2-adrenergic receptor. Localization of the sites of binding, glycosylation, and regulatory phosphorylation by limited proteolysis. , 1987, The Journal of biological chemistry.

[359]  J. Meldolesi,et al.  Dopamine inhibits cytosolic Ca2+ increases in rat lactotroph cells. Evidence of a dual mechanism of action. , 1987, The Journal of biological chemistry.

[360]  R. Wise,et al.  A psychomotor stimulant theory of addiction. , 1987, Psychological review.

[361]  D. Sibley,et al.  Phosphorylation of the beta-adrenergic receptor in intact cells: relationship to heterologous and homologous mechanisms of adenylate cyclase desensitization. , 1987, Archives of biochemistry and biophysics.

[362]  M. Sortino,et al.  Cholinergic stimulation of inositol phosphate production in cultured anterior pituitary cells. , 1987, Neuroendocrinology.

[363]  T. Högberg,et al.  Crystallographic, theoretical and molecular modelling studies on the conformations of the salicylamide, raclopride, a selective dopamine‐D2 antagonist * , 1987, The Journal of pharmacy and pharmacology.

[364]  N. L. Allinger,et al.  The dopaminergic moiety of the ergots: a controversial topic studied with molecular mechanics. , 1987, Journal of medicinal chemistry.

[365]  G. Di Chiara,et al.  Agonist-induced homologous and heterologous sensitization to D-1- and D-2-dependent contraversive turning. , 1987, European journal of pharmacology.

[366]  J. Vincent,et al.  Electrophysiological responses to dopamine of rat hypophysial cells in lactotroph‐enriched primary cultures. , 1987, The Journal of physiology.

[367]  J. Kamien,et al.  Discriminative stimulus properties of D1 and D2 dopamine agonists in rats. , 1987, The Journal of pharmacology and experimental therapeutics.

[368]  D. Klein,et al.  Activation of alpha 1-adrenoceptors, protein kinase C, or treatment with intracellular free Ca2+ elevating agents increases pineal phospholipase A2 activity. Evidence that protein kinase C may participate in Ca2+-dependent alpha 1-adrenergic stimulation of pineal phospholipase A2 activity. , 1987, The Journal of biological chemistry.

[369]  Werner G. Kuhr,et al.  Dopaminergic neurons: simultaneous measurements of dopamine release and single-unit activity during stimulation of the medial forebrain bundle , 1987, Brain Research.

[370]  E. Richfield,et al.  Comparative distribution of dopamine D‐1 and D‐2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys , 1987, The Journal of comparative neurology.

[371]  E. Ongini,et al.  6-Hydroxydopamine-induced degeneration of nigral dopamine neurons: differential effect on nigral and striatal D-1 dopamine receptors. , 1987, Life sciences.

[372]  M. Olianas,et al.  Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice , 1987, Neuroscience Letters.

[373]  G. Gessa,et al.  Apomorphine-induced penile erection and yawning: site of action in brain , 1987, Brain Research.

[374]  A. B. Cubitt,et al.  Activation of Dopamine Receptors Does Not Affect Phosphoinositide Turnover in NCB‐20 Cells , 1987, Journal of neurochemistry.

[375]  A. Cools,et al.  Mesolimbic noradrenaline: Specificity, stability and dose-dependency of individual-specific responses to mesolimbic injections of α-noradrenergic agonists , 1987, Behavioural Brain Research.

[376]  E. Kandel,et al.  Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cells , 1987, Nature.

[377]  M. Starr,et al.  Behavioural evidence for the functionality of D-2 but not D-1 dopamine receptors at multiple brain sites in the 6-hydroxydopamine-lesioned rat. , 1987, European journal of pharmacology.

[378]  Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists. , 1987, European journal of pharmacology.

[379]  A. Friedhoff,et al.  Relationship between receptor occupancy and response at striatal dopamine autoreceptors. , 1987, Molecular pharmacology.

[380]  M. Caron,et al.  A family of receptors coupled to guanine nucleotide regulatory proteins. , 1987, Biochemistry.

[381]  G. Aghajanian,et al.  Pertussis toxin blocks autoreceptor-mediated inhibition of dopaminergic neurons in rat substantia nigra , 1987, Brain Research.

[382]  B. Jenks,et al.  Regulation of cyclic-AMP synthesis in amphibian melanotrope cells through catecholamine and GABA receptors. , 1987, Life sciences.

[383]  T. Chase,et al.  D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. , 1987, Science.

[384]  A. Ashkenazi,et al.  Primary structure and biochemical properties of an M2 muscarinic receptor. , 1987, Science.

[385]  M. Olianas,et al.  Pertussis Toxin Attenuates D2 Inhibition and Enhances D1 Stimulation of Adenylate Cyclase by Dopamine in Rat Striatum , 1987, Journal of neurochemistry.

[386]  Y. Ovchinnikov.  STRUCTURE OF RHODOPSIN AND BACTERIORHODOPSIN , 1987, Photochemistry and photobiology.

[387]  M. Memo,et al.  Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol , 1987, Neuropharmacology.

[388]  J. Palacios,et al.  Dopamine D2 receptors in the rat brain: autoradiographic visualization using a high-affinity selective agonist ligand , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[389]  A. Brown,et al.  The alpha subunit of the GTP binding protein Gk opens atrial potassium channels. , 1987, Science.

[390]  W. Haefely,et al.  Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices. , 1987, European journal of pharmacology.

[391]  M. Caron,et al.  The D2-dopamine receptor of anterior pituitary is functionally associated with a pertussis toxin-sensitive guanine nucleotide binding protein. , 1987, The Journal of biological chemistry.

[392]  K. Jhamandas,et al.  Glutamate‐evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue , 1987, British journal of pharmacology.

[393]  J. Walters,et al.  Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses , 1987, Brain Research.

[394]  B. Bunney,et al.  Activity of A9 and A10 dopaminergic neurons in unrestrained rats: further characterization and effects of apomorphine and cholecystokinin , 1987, Brain Research.

[395]  F. J. White.  D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist. , 1987, European journal of pharmacology.

[396]  C. Altar,et al.  Modulation of In Vivo Dopamine Release by D2 but Not D1 Receptor Agonists and Antagonists , 1987, Journal of neurochemistry.

[397]  D. J. Storey,et al.  Dephosphorylation of myo-inositol 1,4,5-trisphosphate and myo-inositol 1,3,4-triphosphate. , 1987, The Biochemical journal.

[398]  M. Savasta,et al.  Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum , 1987, Neuroscience Letters.

[399]  C. Altar,et al.  In Vivo Assessment of Dopamine and Norepinephrine Release in Rat Neocortex: Gas Chromatography‐Mass Spectrometry Measurement of 3‐Methoxytyramine and Normetanephrine , 1987, Journal of neurochemistry.

[400]  M. Starr,et al.  Topography of dopamine behaviours mediated by D1 and D2 receptors revealed by intrastriatal injection of SKF 38393, lisuride and apomorphine in rats with a unilateral 6-hydroxydopamine-induced lesion , 1987, Neuroscience.

[401]  L. Snell,et al.  Inhibition by phencyclidine of excitatory amino acid-stimulated release of neurotransmitter in the nucleus accumbens , 1987, Neuropharmacology.

[402]  M. Martres,et al.  A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride , 1987, Neuroscience.

[403]  E. Levin,et al.  Opposite effects of a D1 and a D2 agonist on oral movements in rats. , 1987, European journal of pharmacology.

[404]  A. Crocker,et al.  The effects of selective dopamine receptor agonists and antagonists on body temperature in rats. , 1987, European journal of pharmacology.

[405]  T. Ljungberg,et al.  A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis , 1987, Brain Research.

[406]  G. Di Chiara,et al.  Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors. , 1987, Life sciences.

[407]  Makoto Sato,et al.  A single GTP-binding protein regulates K+-channels coupled with dopamine, histamine and acetylcholine receptors , 1987, Nature.

[408]  J. Hyttel,et al.  Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats. , 1987, European journal of pharmacology.

[409]  J. H. Carlson,et al.  Stimulation of both D1 and D2 dopamine receptors appears necessary for full expression of postsynaptic effects of dopamine agonists: a neurophysiological study , 1987, Brain Research.

[410]  F. J. White,et al.  Review: D1 dopamine receptor—the search for a function: A critical evaluation of the D1/D2 dopamine receptor classification and its functional implications , 1987 .

[411]  J. Waddington,et al.  The D-1 Dopamine Receptor and the Search for its Functional Role: From Neurochemistry to Behaviour , 1987, Reviews in the neurosciences.

[412]  S. Stahl,et al.  Antiparkinsonian activity of (+)‐PHNO in the MPTP‐treated common marmoset , 1987, Movement disorders : official journal of the Movement Disorder Society.

[413]  G. Breese,et al.  6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. , 1987, The Journal of pharmacology and experimental therapeutics.

[414]  M. Savasta,et al.  Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat , 1986, Neuroscience Letters.

[415]  G. Di Chiara,et al.  Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. , 1986, European journal of pharmacology.

[416]  R. Romo,et al.  In vivo presynaptic control of dopamine release in the cat caudate nucleus—II. Facilitatory or inhibitory influence ofl-glutamate , 1986, Neuroscience.

[417]  M. Memo,et al.  Dopaminergic Inhibition of Prolactin Release and Calcium Influx Induced by Neurotensin in Anterior Pituitary Is Independent of Cyclic AMP System , 1986, Journal of neurochemistry.

[418]  W. Mason,et al.  Intracellular recordings from bovine anterior pituitary cells: modulation of spontaneous activity by regulators of prolactin secretion. , 1986, Endocrinology.

[419]  T. Chase,et al.  Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors. , 1986, European journal of pharmacology.

[420]  M. Memo,et al.  D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP , 1986, Neuroscience Letters.

[421]  C. Blaha,et al.  In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens , 1986, Brain Research.

[422]  The putatively selective dopamine autoreceptor antagonists (+)-AJ 76 and (+)-UH 232 stimulate prolactin release in rats. , 1986, European journal of pharmacology.

[423]  Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats , 1986, Neuropharmacology.

[424]  G. Aston-Jones,et al.  Nicotinic effects on the firing pattern of midbrain dopamine neurons. , 1986, Acta physiologica Scandinavica.

[425]  S. Nahorski,et al.  Specific Inhibition of Dopamine D‐1‐Mediated Cyclic AMP Formation by Dopamine D‐2, Muscarinic Cholinergic, and Opiate Receptor Stimulation in Rat Striatal Slices , 1986, Journal of neurochemistry.

[426]  I. M. Gardiner,et al.  Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens , 1986, Pharmacology Biochemistry and Behavior.

[427]  P. Molinoff,et al.  Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[428]  L. Snell,et al.  Characterization of the inhibition of excitatory amino acid-induced neurotransmitter release in the rat striatum by phencyclidine-like drugs. , 1986, The Journal of pharmacology and experimental therapeutics.

[429]  A Karlén,et al.  Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences. , 1986, Molecular pharmacology.

[430]  J Ramachandran,et al.  The avian beta-adrenergic receptor: primary structure and membrane topology. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[431]  M. Savasta,et al.  Autoradiographic distribution of the D1 agonist [3H]SKF 38393, in the rat brain and spinal cord. Comparison with the distribution of D2 dopamine receptors , 1986, Neuroscience.

[432]  R. Y. Wang,et al.  Does cholecystokinin potentiate dopamine action in the nucleus accumbens? , 1986, Brain Research.

[433]  G. Di Chiara,et al.  D-1 receptor supersensitivity in the rat striatum after unilateral 6-hydroxydopamine lesions. , 1986, European journal of pharmacology.

[434]  H. Rosengarten,et al.  Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats. , 1986, Life sciences.

[435]  G. Di Chiara,et al.  SCH 23390 antagonizes apomorphine- and ergot-induced hypothermia. , 1986, European journal of pharmacology.

[436]  C. Gallistel.  The role of the dopaminergic projections in MFB self-stimulation , 1986, Behavioural Brain Research.

[437]  J. Palacios,et al.  Autoradiographic localization of high affinity GABA, benzodiazepine, dopaminergic, adrenergic and muscarinic cholinergic receptors in the rat, monkey and human retina , 1986, Brain Research.

[438]  D. Fage,et al.  Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat , 1986, Brain Research.

[439]  J. H. Carlson,et al.  Differential electrophysiological effects of 3-PPP and its enantiomers on dopamine autoreceptors and postsynaptic receptors. , 1986, European journal of pharmacology.

[440]  Brian K. Kobilka,et al.  Cloning of the gene and cDNA for mammalian β-adrenergic receptor and homology with rhodopsin , 1986, Nature.

[441]  J. H. Carlson,et al.  Neurophysiological evidence that D-1 dopamine receptor blockade attenuates postsynaptic but not autoreceptor-mediated effects of dopamine agonists. , 1986, European journal of pharmacology.

[442]  T. Chase,et al.  Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. , 1986, European journal of pharmacology.

[443]  G. Rebec,et al.  Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum , 1986, Brain Research.

[444]  N. Vaysse,et al.  Dopamine receptors in pancreatic acinar cells from dog. , 1986, European journal of pharmacology.

[445]  P. Andrews,et al.  A common structural model for central nervous system drugs and their receptors. , 1986, Journal of medicinal chemistry.

[446]  D. Delbeke,et al.  Dopamine inhibits prolactin release when cyclic adenosine 3',5'-monophosphate levels are elevated. , 1986, Endocrinology.

[447]  F. Sladeczek,et al.  Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. , 1986, The Journal of biological chemistry.

[448]  E. French.  Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat , 1986, Neuropharmacology.

[449]  D. Cooper,et al.  Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process. , 1986, Molecular pharmacology.

[450]  J. Phillis,et al.  Behavioral characteristics of centrally administered adenosine analogs , 1986, Pharmacology Biochemistry and Behavior.

[451]  T. Dawson,et al.  Quantitative autoradiographic localization of central dopamine D-1 and D-2 receptors. , 1986, Advances in experimental medicine and biology.

[452]  P. Canonico,et al.  Angiotensin peptides stimulate phosphoinositide breakdown and prolactin release in anterior pituitary cells in culture. , 1986, Endocrinology.

[453]  P. Needleman,et al.  Arachidonic acid metabolism. , 1986, Annual review of biochemistry.

[454]  I. Creese,et al.  Neurobiology of Central D1-Dopamine Receptors , 1986, Advances in Experimental Medicine and Biology.

[455]  S. Lazareno,et al.  Differential effects of selective and non-selective neuroleptics on intracellular and extracellular cyclic AMP accumulation in rat striatal slices , 1985, Brain Research.

[456]  M. Martres,et al.  Localisation and pharmacological characterisation of D-2 dopamine receptors in rat cerebral neocortex and cerebellum using [125I]iodosulpride. , 1985, European journal of pharmacology.

[457]  P. Clarke,et al.  Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons , 1985, Brain Research.

[458]  G. Di Chiara,et al.  Catalepsy induced by SCH 23390 in rats. , 1985, European journal of pharmacology.

[459]  T. Di Paolo,et al.  17 beta-Estradiol at a physiological dose acutely increases dopamine turnover in rat brain. , 1985, European journal of pharmacology.

[460]  J. Vincent,et al.  The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine. , 1985, Endocrinology.

[461]  N. Ben-Jonathan.  Dopamine: a prolactin-inhibiting hormone. , 1985, Endocrine reviews.

[462]  G. Koob,et al.  Low doses of methylnaloxonium in the nucleus accumbens antagonize hyperactivity induced by heroin in the rat , 1985, Pharmacology Biochemistry and Behavior.

[463]  H. Gerschenfeld,et al.  Two different mechanisms of calcium spike modulation by dopamine , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[464]  P. Vidal,et al.  The neuropeptide FMRF-amide decreases both the Ca2+ conductance and a cyclic 3',5'-adenosine monophosphate-dependent K+ conductance in identified molluscan neurons , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[465]  I. Creese,et al.  D2dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum , 1985, Neuroscience Letters.

[466]  J. Palacios,et al.  Autoradiographic studies on dopamine D2 receptors in rat pituitary: Influence of hormonal states , 1985, Neuroscience Letters.

[467]  M. Olianas,et al.  Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum. , 1985, Molecular pharmacology.

[468]  P. Clarke,et al.  Electrophysiological actions of nicotine on substantia nigra single units , 1985, British journal of pharmacology.

[469]  M. Lokhandwala,et al.  Pharmacological analysis of the actions of SKF 82526 on cardiovascular dopamine receptors. , 1985, The Journal of pharmacology and experimental therapeutics.

[470]  S. Paul,et al.  Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[471]  R. Wightman,et al.  Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat , 1985, Brain Research.

[472]  J. Joyce,et al.  Dopamine D-2 receptors in rat caudate-putamen: the lateral to medial gradient does not correspond to dopaminergic innervation , 1985, Brain Research.

[473]  N. Maidment,et al.  In vivo voltammetric and behavioural evidence for somatodendritic autoreceptor control of mesolimbic dopamine neurones , 1985, Brain Research.

[474]  J. Arnt.  Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. , 1985, European journal of pharmacology.

[475]  B. Scatton,et al.  Heterogeneous distribution of dopamine D2 receptors within the rat striatum as revealed by autoradiography of [3 H]N-n-propylnorapomorphine binding sites , 1985, Neuroscience Letters.

[476]  J. Bockaert,et al.  D2-dopamine receptor-mediated inhibition of cyclic AMP formation in striatal neurons in primary culture. , 1985, Molecular pharmacology.

[477]  E. Ongini,et al.  SCH 23390, a selective dopamine D1 antagonist, activates dopamine neurons but fails to prevent their inhibition by apomorphine. , 1985, European journal of pharmacology.

[478]  E. B. Nielsen,et al.  Antagonism of the amphetamine cue by both classical and atypical antipsychotic drugs. , 1985, European journal of pharmacology.

[479]  C. Altar,et al.  Brain dopamine and serotonin receptor sites revealed by digital subtraction autoradiography. , 1985, Science.

[480]  R. Dreher,et al.  Catalytic unit of adenlyate cyclase: purification and identification by affinity crosslinking. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[481]  M. J. Christie,et al.  Excitotoxin lesions suggest an aspartatergic projection from rat medial prefrontal cortex to ventral tegmental area , 1985, Brain Research.

[482]  J. Gordon,et al.  The possible role of 2-hydroxyestradiol in the development of estrogen-induced striatal dopamine receptor hypersensitivity , 1985, Brain Research.

[483]  B. Scatton,et al.  Autoradiographic localization of D1 dopamine receptors in the rat brain with [3H]SKF 38393. , 1985, European journal of pharmacology.

[484]  P. Mitchell,et al.  Dopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesis , 1985, British journal of pharmacology.

[485]  F. Gonon,et al.  Regulation of dopamine release by impulse flow and by autoreceptors as studied by in vivo voltammetry in the rat striatum , 1985, Neuroscience.

[486]  Y. Claustre,et al.  Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors. , 1985, The Journal of pharmacology and experimental therapeutics.

[487]  D. Clark,et al.  Dopamine receptor-mediated hypothermia induced in rats by (+)-, but not by (-)-3-PPP. , 1985, European journal of pharmacology.

[488]  M. Memo,et al.  Cellular mechanisms for neurotensin receptor-mediated release of prolactin. , 1985, Regulatory peptides. Supplement.

[489]  J. C. Stoof,et al.  Two dopamine receptors: biochemistry, physiology and pharmacology. , 1984, Life sciences.

[490]  P. Sternweis,et al.  Isolation of two proteins with high affinity for guanine nucleotides from membranes of bovine brain. , 1984, The Journal of biological chemistry.

[491]  F. J. White,et al.  Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies. , 1984, The Journal of pharmacology and experimental therapeutics.

[492]  A. Grace,et al.  The control of firing pattern in nigral dopamine neurons: burst firing , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[493]  U. Ungerstedt,et al.  Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis. , 1984, European journal of pharmacology.

[494]  C. Gerfen.  The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems , 1984, Nature.

[495]  J. Clemens,et al.  Brain dialysis in conscious rats confirms in vivo electrochemical evidence that dopaminergic stimulation releases ascorbate. , 1984, Life sciences.

[496]  P. Seeman,et al.  D2 dopamine receptor density in rat striatum over 24 hours: lack of detectable changes. , 1984, Biological psychiatry.

[497]  J. Nathans,et al.  Isolation and nucleotide sequence of the gene encoding human rhodopsin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[498]  R. Sekura,et al.  Altered activity of the inhibitory guanyl nucleotide-binding component (Ni) induced by pertussis toxin. Uncoupling of Ni from receptor with continued coupling of Ni to the catalytic unit. , 1984, The Journal of biological chemistry.

[499]  J. Hyttel,et al.  Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions. , 1984, European journal of pharmacology.

[500]  R. Mailman,et al.  SCH-23390: a selective D1 dopamine antagonist with potent D2 behavioral actions. , 1984, European journal of pharmacology.

[501]  R. Roth,et al.  Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons , 1984, Neuroscience.

[502]  G. Di Chiara,et al.  Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites , 1984, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[503]  G. Gessa,et al.  Selective blockade of dopamine D-1 receptors by SCH 23390 discloses striatal dopamine D-2 receptors mediating the inhibition of adenylate cyclase in rats. , 1984, European journal of pharmacology.

[504]  A. Gilman.  G proteins and dual control of adenylate cyclase , 1984, Cell.

[505]  J. Kebabian,et al.  Forskolin stimulates adenylate cyclase activity, adenosine 3',5'-monophosphate production and peptide release from the intermediate lobe of the rat pituitary gland. , 1984, Endocrinology.

[506]  R. Romo,et al.  Effects of electrical stimulation of various midline thalamic nuclei on the bilateral release of dopamine from dendrites and nerve terminals of neurons in the nigro-striatal dopaminergic pathways , 1984, Neuroscience Letters.

[507]  Anthony G. Phillips,et al.  Brain reward circuitry: A case for separate systems , 1984, Brain Research Bulletin.

[508]  D. Jackson,et al.  Dopamine applied into the nucleus accumbens and discriminative avoidance in rats , 1984, Pharmacology Biochemistry and Behavior.

[509]  G. Chiara,et al.  Output Pathways Mediating Basal Ganglia Function , 1984 .

[510]  S. Lal,et al.  Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons , 1983, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[511]  J. Lehmann,et al.  The striatal cholinergic interneuron: Synaptic target of dopaminergic terminals? , 1983, Neuroscience.

[512]  R. Duvoisin,et al.  Behavioral correlations of dopamine receptor activation , 1983, Neurology.

[513]  P. Kalivas,et al.  Enkephalin action on the mesolimbic system: a dopamine-dependent and a dopamine-independent increase in locomotor activity. , 1983, The Journal of pharmacology and experimental therapeutics.

[514]  J. Nathans,et al.  Isolation, sequence analysis, and intron-exon arrangement of the gene encoding bovine rhodopsin , 1983, Cell.

[515]  F. J. White,et al.  Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons. , 1983, Science.

[516]  J. Schofield.  Use of a trapped fluorescent indicator to demonstrate effects of thyroliberin and dopamine on cytoplasmic calcium concentrations in bovine anterior pituitary cells , 1983, FEBS letters.

[517]  J. Phillis,et al.  Central effects of adenosine analogs on locomotor activity in mice and antagonism of caffeine , 1983, Brain Research.

[518]  N. Uretsky,et al.  Effects of excitatory amino acids on locomotor activity after bilateral microinjection into the rat nucleus accumbens: Possible dependence on dopaminergic mechanisms , 1983, Neuropharmacology.

[519]  B. Bunney,et al.  Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neurons , 1983, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[520]  M. Schlumpf,et al.  Ontogeny of diurnal rhythms of central dopamine, serotonin and spirodecanone binding sites and of motor activity in the rat. , 1983, Life sciences.

[521]  P. Kelly,et al.  Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi , 1983, Pharmacology Biochemistry and Behavior.

[522]  M. Cronin,et al.  Adenosine 3',5'-monophosphate (cAMP) and calcium-calmodulin interrelation in the control of prolactin secretion: evidence for dopamine inhibition of cAMP accumulation and prolactin release after calcium mobilization. , 1983, Endocrinology.

[523]  K. Franklin,et al.  Differential effects of amphetamine isomers on SN self-stimulation: Evidence for DA neuron subtypes , 1983, Pharmacology Biochemistry and Behavior.

[524]  S. Ahlénius,et al.  Suppression of exploratory locomotor activity in the rat by the local application of 3-PPP enantiomers into the nucleus accumbens. , 1983, European journal of pharmacology.

[525]  D. Jackson,et al.  Self-stimulation of the nucleus accumbens and some comparisons with hypothalamic self-stimulation , 1983, Pharmacology Biochemistry and Behavior.

[526]  R. Roth,et al.  Pharmacology of mesocortical dopamine neurons. , 1983, Pharmacological reviews.

[527]  T. Kuno,et al.  Solubilization of D2 Dopamine Receptor Coupled to Guanine Nucleotide Regulatory Protein from Bovine Striatum , 1983, Journal of neurochemistry.

[528]  F. J. White,et al.  Comparison of the effects of chronic haloperidol treatment on A9 and A10 dopamine neurons in the rat. , 1983, Life sciences.

[529]  E. Hewlett,et al.  Identification of the predominant substrate for ADP-ribosylation by islet activating protein. , 1983, The Journal of biological chemistry.

[530]  L. I. Goldberg,et al.  Peripheral dopamine receptors: A classification based on potency series and specific antagonism , 1983 .

[531]  K. Jhamandas,et al.  Regional release of [3H]dopamine from rat brain in vitro: effects of opioids on release induced by potassium, nicotine, and L-glutamic acid. , 1983, Canadian journal of physiology and pharmacology.

[532]  E. Hewlett,et al.  Pertussis toxin actions on the pituitary-derived 235-1 clone: effects of PGE1, cholera toxin, and forskolin on cyclic AMP metabolism and prolactin release. , 1983, Journal of cyclic nucleotide and protein phosphorylation research.

[533]  M. Starr,et al.  Multifocal brain sites for apomorphine-induced circling and other stereotyped motor behaviour in the 6-hydroxydopamine-lesioned rat , 1982, Neuroscience Letters.

[534]  B. Scatton.  Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmission. , 1982, Life sciences.

[535]  T. Di Paolo,et al.  Effect of prolactin and estradiol on rat striatal dopamine receptors. , 1982, Life sciences.

[536]  R. Ruffolo.  IMPORTANT CONCEPTS OF RECEPTOR THEORY , 1982 .

[537]  J. C. Stoof,et al.  Independent in vitro regulation by the D-2 dopamine receptor of dopamine-stimulated efflux of cyclic AMP and K+-stimulated release of acetylcholine from rat neostriatum , 1982, Brain Research.

[538]  J. C. Stoof,et al.  Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. , 1982, European journal of pharmacology.

[539]  S. Hunt,et al.  Localization of [3H]spiperone binding sites in the intermediate lobe of the rat pituitary gland , 1982, Neuroscience Letters.

[540]  E. Melamed,et al.  Stimulation of nigrostriatal dopamine neurones by nicotine , 1982, Neuropharmacology.

[541]  M. Lokhandwala,et al.  Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. , 1982, Journal of autonomic pharmacology.

[542]  D. Sibley,et al.  Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptors. , 1982, Life sciences.

[543]  S. Lazareno,et al.  Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. , 1982, European journal of pharmacology.

[544]  K. Starke,et al.  Are presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in the rabbit caudate nucleus pharmacologically different? , 1982, Neuroscience.

[545]  D. Cooper.  Bimodal regulation of adenylate cyclase , 1982, FEBS letters.

[546]  A. Delini-Stula,et al.  Effect of yohimbine and its diastereoisomers on clonidine-induced depression of exploration in the rat. , 1982, European journal of pharmacology.

[547]  J. C. Stoof,et al.  Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum , 1981, Nature.

[548]  H. Meltzer,et al.  A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat. , 1981, European journal of pharmacology.

[549]  J. Rehfeld,et al.  Peptide-monoamine coexistence: Studies of the actions of cholecystokinin-like peptide on the electrical activity of midbrain dopamine neurons , 1981, Neuroscience.

[550]  F. Gonon,et al.  Voltammetry in the striatum of chronic freely moving rats: Detection of catechols and ascorbic acid , 1981, Brain Research.

[551]  J. P. Schwartz,et al.  Dopaminergic modulation of adenylate cyclase stimulation by vasoactive intestinal peptide in anterior pituitary. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[552]  P. Dannies,et al.  The role of adenosine 3',5'-monophosphate in dopaminergic inhibition of prolactin release in anterior pituitary cells. , 1981, Endocrinology.

[553]  G. Fischbach,et al.  Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. , 1981, The Journal of physiology.

[554]  G. Wolterink,et al.  Injection of low doses of apomorphine into the nucleus accumbens of rats reduces locomotor activity. , 1981, European journal of pharmacology.

[555]  R. Davis,et al.  Behavioral effects of unilateral dopamine injection into dorsal or ventral striatum. , 1981, European journal of pharmacology.

[556]  R. Duvoisin,et al.  The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats , 1981, Brain Research.

[557]  S H Snyder,et al.  Adenosine receptors and behavioral actions of methylxanthines. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[558]  G. Giannattasio,et al.  Dopamine-inhibited adenylate cyclase in female rat adenohypophysis. , 1981, Life sciences.

[559]  B. Cox,et al.  Characterisation of Inhibitory 5‐Hydroxytryptamine Receptors That Modulate Dopamine Release in the Striatum , 1981, Journal of neurochemistry.

[560]  C. Kornetsky,et al.  Reward and detection thresholds for brain stimulation: dissociative effects of cocaine , 1981, Brain Research.

[561]  J. Meek,et al.  Evidence for a tonic GABAergic control of serotonin neurons in the median raphe nucleus , 1981, Brain Research.

[562]  J. Kebabian,et al.  Stimulation of a D-2 dopamine receptor in the intermediate lobe of the rat pituitary gland decreases the responsiveness of the beta-adrenoceptor: biochemical mechanism. , 1981, Endocrinology.

[563]  J. Dowling,et al.  Dopaminergic Mechanisms in the Teleost Retina , 1981, Journal of neurochemistry.

[564]  G. Mogenson,et al.  Injections of dopaminergic, cholinergic, serotoninergic and gabaergic drugs into the nucleus accumbens: effects on locomotor activity in the rat , 1981, Neuropharmacology.

[565]  Douglas L. Jones,et al.  From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.

[566]  J. Kebabian,et al.  The Dopamine Receptor in the Intermediate Lobe of the Rat Pituitary Gland: Pharmacological Characterization , 1980 .

[567]  V. I. Novoselov,et al.  The release of labeledl-glutamic acid from rat neostriatum In vivo following stimulation of frontal cortex , 1980, Neuroscience.

[568]  G. Mogenson,et al.  Effect of picrotoxin and nipecotic acid on inhibitory response of dopaminergic neurons in the ventral tegmental area to stimulation of the nucleus accumbens , 1980, Brain Research.

[569]  P. Seeman.  Brain dopamine receptors. , 1980, Pharmacological reviews.

[570]  J. C. Stoof,et al.  Simultaneous demonstration of the activation of presynaptic dopamine autoreceptors and postsynaptic dopamine receptors in vitro by N,N-dipropyl-5,6-ADTN , 1980, Brain Research.

[571]  D. Cooper,et al.  Selective effects of organic mercurials on the GTP-regulatory proteins of adenylate cyclase systems. , 1980, The Journal of biological chemistry.

[572]  Douglas L. Jones,et al.  Locomotor activity elicited by injections of picrotoxin into the ventral tegmental area is attenuated by injections of GABA into the globus pallidus , 1980, Brain Research.

[573]  J. Kebabian,et al.  Release of α-Melanocyte-Stimulating Hormone from Dispersed Cells of the Intermediate Lobe of the Rat Pituitary Gland: Involvement of Catecholamines and Adenosine 3′,5′-Monophosphate , 1980 .

[574]  H. Fibiger,et al.  Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens , 1980, Pharmacology Biochemistry and Behavior.

[575]  G. Mogenson,et al.  Nucleus accumbens to globus pallidus GABA projection: Electrophysiological and iontophoretic investigations , 1980, Brain Research.

[576]  T. Hattori,et al.  Dorsal raphe cells with collateral projections to the caudate-putamen and substantia nigra: A fluorescent retrograde double labeling study in the rat , 1980, Brain Research.

[577]  Martin Rodbell,et al.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction , 1980, Nature.

[578]  F. Fonnum,et al.  Biochemical evidence for γ-aminobutyrate containing fibres from the nucleus accumbens to the substantia nigra and ventral tegmental area in the rat , 1980, Neuroscience.

[579]  J. Scheel-Krüger,et al.  Behavioural functions of GABA in basal ganglia and limbic system , 1979, Brain Research Bulletin.

[580]  N. Andén.  Regulation of Monoamine Synthesis and Utilization by Receptors , 1980 .

[581]  N. Andén,et al.  Effects of the GABA receptor agonist muscimol on the turnover of brain dopamine and on the motor activity of rats. , 2009, Acta pharmacologica et toxicologica.

[582]  J. Vincent,et al.  Dopamine inhibition of action potentials in a prolactin secreting cell line is modulated by oestrogen , 1979, Nature.

[583]  K. Jakobs.  Inhibition of adenylate cyclase by hormones and neurotransmitters , 1979, Molecular and Cellular Endocrinology.

[584]  J. Glowinski,et al.  Increased utilization of dopamine in the nucleus accumbens but not in the cerebral cortex after dorsal raphe lesion in the rat , 1979, Neuroscience Letters.

[585]  H. Fibiger,et al.  The localization of receptor binding sites in the substantia nigra and striatum of the rat , 1979, Brain Research.

[586]  S. Ozawa,et al.  Membrane potential changes caused by thyrotropin-releasing hormone in the clonal GH3 cell and their relationship to secretion of pituitary hormone. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[587]  J. Scheel-Krüger,et al.  GABA in the ventral tegmental area: differential regional effects on locomotion, aggression and food intake after microinjection of GABA agonists and antagonists. , 1979, Life sciences.

[588]  M. Le Moal,et al.  Is the dopaminergic mesocorticolimbic system necessary for intracranial self-stimulation? Biochemical and behavioral studies from A10 cell bodies and terminals. , 1979, Behavioral and neural biology.

[589]  C. Carter,et al.  A comparison of l- and d-baclofen on dopamine dependent behaviour in the rat , 1979, Neuropharmacology.

[590]  H. H. Harms,et al.  Effects of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum , 1979, Neuropharmacology.

[591]  H. Fibiger,et al.  Localization of dopamine receptors in rat brain , 1979, Brain Research.

[592]  P. Roberts,et al.  STIMULATORY EFFECT OF l‐GLUTAMATE AND RELATED AMINO ACIDS ON [3H]DOPAMINE RELEASE FROM RAT STRIATUM: AN IN VITRO MODEL FOR GLUTAMATE ACTIONS , 1979, Journal of neurochemistry.

[593]  P. Camilli,et al.  Dopamine inhibits adenylate cyclase in human prolactin-secreting pituitary adenomas , 1979, Nature.

[594]  G. Mogenson,et al.  Locomotor activity initiated by microinfusions of picrotoxin into the ventral tegmental area , 1979, Brain Research.

[595]  J. Kebabian,et al.  Multiple receptors for dopamine , 1979, Nature.

[596]  W. Douglas,et al.  Catecholamines of supposed inhibitory hypophysiotrophic function suppress action potentials in prolactin cells , 1978, Nature.

[597]  N. Sharif,et al.  Effects ofl-glutamate and related amino acids upon the release of [3H]dopamine from rat striatal slices , 1978, Brain Research.

[598]  A. Grace,et al.  Acute and chronic haloperidol treatment: comparison of effects on nigral dopaminergic cell activity. , 1978, Life sciences.

[599]  H. Sarau,et al.  The central effects of a novel dopamine agonist. , 1978, European journal of pharmacology.

[600]  J. Fallon,et al.  Catecholamine innervation of the basal forebrain IV. Topography of the dopamine projection to the basal forebrain and neostriatum , 1978, The Journal of comparative neurology.

[601]  K. Fuxe,et al.  Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders. , 1978, Pharmacology.

[602]  G. P. Smith,et al.  Efferent connections and nigral afferents of the nucleus accumbens septi in the rat , 1978, Neuroscience.

[603]  J. Glowinski,et al.  Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the frontocortical dopaminergic innervation in the rat , 1978, Brain Research.

[604]  G. Brown,et al.  Dopamine receptors in the central nervous system. , 1978, Federation proceedings.

[605]  C. Marsden,et al.  The rotating rodent: a two component system? , 1978, European journal of pharmacology.

[606]  P. Spano,et al.  Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system. , 1978, Advances in biochemical psychopharmacology.

[607]  A. Cools,et al.  Muscimol a GABA-agonist injected into the nucleus accumbens increases apomorphine stereotypy and decreases the motility. , 1977, Life sciences.

[608]  T. Pfeuffer.  GTP-binding proteins in membranes and the control of adenylate cyclase activity. , 1977, The Journal of biological chemistry.

[609]  W. Douglas,et al.  Action potentials occur in cells of the normal anterior pituitary gland and are stimulated by the hypophysiotropic peptide thyrotropin-releasing hormone. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[610]  R. Hassler,et al.  Effect of frontal cortex ablation on striatal glutamic acid level in rat , 1977, Brain Research.

[611]  R. Clavier,et al.  On the role of ascending catecholaminergic projections in intracranial self-stimulation of the substantia nigra , 1977, Brain Research.

[612]  S. Snyder,et al.  Dopamine receptor binding enhancement accompanies lesion-induced behavioral supersensitivity. , 1977, Science.

[613]  D. Cassel,et al.  Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[614]  G. Di Chiara,et al.  Localization of nigral dopamine-sensitive adenylate cyclase on neurons originating from the corpus striatum. , 1977, Science.

[615]  P. Mcgeer,et al.  A glutamatergic corticostriatal path? , 1977, Brain Research.

[616]  I. Divac,et al.  High affinity uptake of glutamate in terminals of corticostriatal axons , 1977, Nature.

[617]  A. Pert,et al.  Neuroanatomical focus for morphine and enkaphalin-induced hypermotility , 1977, Nature.

[618]  A. Tischler,et al.  Electrical excitability of cultured adrenal chromaffin cells. , 1976, The Journal of physiology.

[619]  B. Roufogalis,et al.  Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists. , 1976, Life sciences.

[620]  M. Palkovits,et al.  Regional concentrations of noradrenaline and dopamine in rat brain , 1976, Brain Research.

[621]  V. Klimek,et al.  On the anticataleptic action of cyproheptadine , 1976, Pharmacology Biochemistry and Behavior.

[622]  Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat. , 1976, Archives internationales de pharmacodynamie et de therapie.

[623]  R. Roth,et al.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. , 1976, European journal of pharmacology.

[624]  A. M. Johnson,et al.  STIMULANT PROPERTIES OF BROMOCRIPTINE ON CENTRAL DOPAMINE RECEPTORS IN COMPARISON TO APOMORPHINE, (+)‐AMPHETAMINE AND l‐DOPA , 1976, British journal of pharmacology.

[625]  Y. Kidokoro.  Spontaneous calcium action potentials in a clonal pituitary cell line and their relationship to prolactin secretion , 1975, Nature.

[626]  P. Kelly.  Unilateral 6-hydroxydopamine lesions of nigrostriatal or mesolimbic dopamine-containing terminals and the drug-induced rotation of rats , 1975, Brain Research.

[627]  C. Marsden,et al.  Serotonergic involvement with neuroleptic catalepsy , 1975, Neuropharmacology.

[628]  S. Iversen,et al.  Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum , 1975, Brain Research.

[629]  R. Henderson,et al.  Three-dimensional model of purple membrane obtained by electron microscopy , 1975, Nature.

[630]  Jackson Dm.  The effect of beta-phenylethylamine on temperature in mice and its possible mechanisms of action. , 1975 .

[631]  G. Woodruff,et al.  STUDIES ON THE BEHAVIOURAL PHARMACOLOGY OF A CYCLIC ANALOGUE OF DOPAMINE FOLLOWING ITS INJECTION INTO THE BRAINS OF CONSCIOUS RATS , 1975, British journal of pharmacology.

[632]  M. Trabucchi,et al.  In vivo inhibition of striatal acetylcholine turnover by L-DOPA, apomorphine and (+)-amphetamine , 1975, Brain Research.

[633]  J. Rossier,et al.  Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system , 1975, Brain Research.

[634]  U. Strömbom.  On the functional role of pre- and postsynaptic catecholamine receptors in brain. , 1975, Acta physiologica Scandinavica. Supplementum.

[635]  M. Haddox,et al.  Biologic regulation through opposing influences of cyclic GMP and cyclic AMP: the Yin Yang hypothesis. , 1975, Advances in cyclic nucleotide research.

[636]  R. Katzman.,et al.  Enhancement of dopamine-stimulated adenylate cyclase activity in rat caudate after lesions in substantia nigra: evidence for denervation supersensitivity. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[637]  S. Ahlénius.  Effects of L-DOPA on conditioned avoidance responding after behavioural suppression by alpha-methyltyrosine or reserpine in mice. , 1974, Neuropharmacology.

[638]  D. Jackson.  The involvement of noradrenergic systems in the locomotor activity stimulation in mice produced by β‐phenethylamine , 1974, The Journal of pharmacy and pharmacology.

[639]  C. Leonard,et al.  Connections of the median and dorsal raphe nuclei in the rat: An autoradiographic and degeneration study , 1974, The Journal of comparative neurology.

[640]  H. Leitich,et al.  Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[641]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[642]  K. E. Moore,et al.  A comparison of effects of apomorphine and ET495 on locomotor activity and circling behaviour in mice. , 1974, Neuropharmacology.

[643]  R. Miller,et al.  DOPAMINE IN THE MESOLIMBIC SYSTEM OF THE RAT BRAIN: ENDOGENOUS LEVELS AND THE EFFECTS OF DRUGS ON THE UPTAKE MECHANISM AND STIMULATION OF ADENYLATE CYCLASE ACTIVITY , 1974, Journal of neurochemistry.

[644]  R. Miller,et al.  Effect of chlorpromazine and some of its metabolites on the dopamine‐sensitive adenylate cyclase of rat brain striatum , 1974, The Journal of pharmacy and pharmacology.

[645]  G. Johnson,et al.  Dopaminergic denervation supersensitivity and dopamine stimulated adenyl cyclase activity. , 1973, Neuropharmacology.

[646]  J. V. van Rossum,et al.  Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens. , 1973, Brain research.

[647]  M. Makman,et al.  Influence of neuroleptic drugs and apomorphine on dopamine‐sensitive adenylate cyclase of retina , 1973, Journal of neurochemistry.

[648]  R. Roth,et al.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. , 1973, The Journal of pharmacology and experimental therapeutics.

[649]  T. Hökfelt,et al.  Effect of ergot drugs on central catecholamine neurons: Evidence for a stimulation of central dopamine neurons , 1973, The Journal of pharmacy and pharmacology.

[650]  W. Kostowski,et al.  Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine. , 1972, Brain research.

[651]  H. Nagasawa,et al.  Promotion of pituitary prolactin release in rats by dibutyryl adenosine 3',5'-monophosphate. , 1972, The Journal of endocrinology.

[652]  K. Fuxe,et al.  Heterogeneity of striatal and limbic dopamine innervation: highly fluorescent islands in developing and adult rats. , 1972, Brain research.

[653]  A. Carlsson,et al.  Evidence for a receptor‐mediated feedback control of striatal tyrosine hydroxylase activity , 1972, The Journal of pharmacy and pharmacology.

[654]  P. Greengard,et al.  Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor". , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[655]  J. Clemens,et al.  Hypothalamic control of prolactin secretion. , 1972, Vitamins and hormones.

[656]  P. Greengard,et al.  Dopamine-Sensitive Adenyl Cyclase: Possible Role in Synaptic Transmission , 1971, Science.

[657]  U. Ungerstedt.  Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. , 1971, Acta physiologica Scandinavica. Supplementum.

[658]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[659]  U. Ungerstedt,et al.  Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. , 1971, European journal of pharmacology.

[660]  B. Costall,et al.  Cholinergic- and neuroleptic-induced catalepsy: modification by lesions in the caudate-putamen. , 1971, Neuropharmacology.

[661]  B. Hamberger,et al.  Drug-Induced Changes in the Release of 3H-Monoamines from Field Stimulated Rat Brain Slices , 1971 .

[662]  L. Birnbaumer,et al.  The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. V. An obligatory role of guanylnucleotides in glucagon action. , 1971, The Journal of biological chemistry.

[663]  T. Crow,et al.  Relation of contraversive turning to unilateral release of dopamine from the nigrostriatal pathway in rats. , 1971, Experimental neurology.

[664]  R. Butcher,et al.  ADENYL CYCLASE AS AN ADRENERGIC RECEPTOR * , 1967, Annals of the New York Academy of Sciences.

[665]  J. Scheel-Krüger,et al.  Diethyldithiocarbamate and amphetamine stereotype behaviour , 1966, The Journal of pharmacy and pharmacology.

[666]  J C SKOU,et al.  ENZYMATIC BASIS FOR ACTIVE TRANSPORT OF NA+ AND K+ ACROSS CELL MEMBRANE. , 1965, Physiological reviews.

[667]  E. Sutherland,et al.  Adenyl Cyclase I. DISTRIBUTION, PREPARATION, AND PROPERTIES , 1962 .

[668]  E. Sutherland,et al.  Adenyl cyclase. II. The enzymatically catalyzed formation of adenosine 3',5'-phosphate and inorganic pyrophosphate from adenosine triphosphate. , 1962, The Journal of biological chemistry.

[669]  E. Sutherland,et al.  Fractionation and characterization of a cyclic adenine ribonucleotide formed by tissue particles. , 1958, The Journal of biological chemistry.